OR51E2 is known to function as a biomarker for prostate cancer, and its paralog, OR51E1, was discovered as a potent biomarker for the small intestine and some types of lung cancer (13, 14, 22, 23). The gene discussed is OR51E2; the disease is prostate carcinoma.